Annual EBITDA
-$141.71M$87.60M-161.89%
Summary
- Current Value
- As of today, MLTX annual EBITDA is -$141.71M, down -161.89% on
- Historical Performance
- MLTX annual EBITDA is down -164.52% over the past 3 years, and down -133837.90% over the past 5 years
- All-Time High Comparison
- MLTX annual EBITDA is currently -133837.90% below its historical high of -$105.80K set on
- 3-Year Low Comparison
- MLTX annual EBITDA is at its 3-year low
- Sector Comparison
- MLTX annual EBITDA is higher than 12.40% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$141.71M | -161.9% | -164.5% | -10000.0% | -10000.0% | |
| Quarterly EBITDA | -$70.69M | -64.1% | -378.7% | -100.0% | -100.0% | |
| TTM EBITDA | -$226.03M | -108.4% | -260.9% | -100.0% | -100.0% | |
| Price | $18.49 | -61.6% | +52.9% | +60.8% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual EPS | -$1.89 | -158.1% | +72.3% | -10000.0% | -10000.0% | |
| Annual EBIT | -$143.09M | -164.4% | -167.1% | -10000.0% | -10000.0% | |
| Annual Net Income | -$121.24M | -175.1% | -126.0% | -10000.0% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$54.11M | -161.9% | |
| 5Y | -$105.80K | N/A | >-9999.0% |
| All | -$105.80K | >-9999.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$141.71M | at low | |
| 5Y | -$141.71M | at low | |
| All | -$141.71M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$141.71M | -161.9% | |
| -$54.11M | +16.8% | |
| -$65.05M | -21.4% |
| Year | Value | Change |
|---|---|---|
| -$53.57M | >-9,900.0% | |
| -$105.80K | - |
FAQ
What is the current annual EBITDA of MLTX?
As of today, MLTX annual EBITDA is -$141.71M
What is 1-year change in MLTX annual EBITDA?
MLTX annual EBITDA is down -161.89% year-over-year
What is 3-year change in MLTX annual EBITDA?
MLTX annual EBITDA is down -164.52% over the past 3 years
How far is MLTX annual EBITDA from its all-time high?
MLTX annual EBITDA is currently -133837.90% below its historical high of -$105.80K set on December 1, 2020
How does MLTX annual EBITDA rank versus sector peers?
MLTX annual EBITDA is higher than 12.40% of companies in Healthcare sector
When is MLTX next annual earnings release?
The next annual earnings release for MLTX is on
Quarterly EBITDA
-$70.69M$10.73M-17.90%
Summary
- Current Value
- As of today, MLTX quarterly EBITDA is -$70.69M, down -17.90% on
- Historical Performance
- MLTX quarterly EBITDA is down -64.09% year-over-year, and down -378.69% over the past 3 years
- All-Time High Comparison
- MLTX quarterly EBITDA vs all-time high is unknown
- 3-Year Low Comparison
- MLTX quarterly EBITDA is at its 3-year low
- Sector Comparison
- MLTX quarterly EBITDA is higher than 5.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$70.69M | -17.9% | -64.1% | -378.7% | -100.0% | |
| Annual EBITDA | -$141.71M | – | -161.9% | -164.5% | -10000.0% | |
| TTM EBITDA | -$226.03M | -13.9% | -108.4% | -260.9% | -100.0% | |
| Price | $18.49 | +97.1% | -61.6% | +52.9% | +60.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly EPS | -$1.10 | -26.1% | -95.6% | -301.9% | -10000.0% | |
| Quarterly EBIT | -$71.43M | -17.7% | -65.7% | -383.6% | -100.0% | |
| Quarterly Net Income | -$70.69M | -26.1% | -95.8% | -379.6% | -10000.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$47.11M | -50.1% | |
| 3Y | -$12.93M | -446.8% | |
| 5Y | -$94.10K | >-9999.0% | |
| All | $0.00 | N/A |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$70.69M | at low | |
| 3Y | -$70.69M | at low | |
| 5Y | -$70.69M | at low | |
| All | -$70.69M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MLTX?
As of today, MLTX quarterly EBITDA is -$70.69M
What is MLTX quarterly EBITDA most recent change?
MLTX quarterly EBITDA was down -17.90% on September 30, 2025
What is 1-year change in MLTX quarterly EBITDA?
MLTX quarterly EBITDA is down -64.09% year-over-year
How far is MLTX quarterly EBITDA from its all-time high?
MLTX quarterly EBITDA vs all-time high is unknown
How does MLTX quarterly EBITDA rank versus sector peers?
MLTX quarterly EBITDA is higher than 5.25% of companies in Healthcare sector
When is MLTX next earnings release?
The next earnings release for MLTX is on
TTM EBITDA
-$226.03M$27.61M-13.91%
Summary
- Current Value
- As of today, MLTX TTM EBITDA is -$226.03M, down -13.91% on
- Historical Performance
- MLTX TTM EBITDA is down -108.41% year-over-year, and down -260.88% over the past 3 years
- All-Time High Comparison
- MLTX TTM EBITDA vs all-time high is unknown
- 3-Year Low Comparison
- MLTX TTM EBITDA is at its 3-year low
- Sector Comparison
- MLTX TTM EBITDA is higher than 5.88% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$226.03M | -13.9% | -108.4% | -260.9% | -100.0% | |
| Annual EBITDA | -$141.71M | – | -161.9% | -164.5% | -10000.0% | |
| Quarterly EBITDA | -$70.69M | -17.9% | -64.1% | -378.7% | -100.0% | |
| Price | $18.49 | +97.1% | -61.6% | +52.9% | +60.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| TTM EPS | -$3.33 | -19.3% | -157.8% | +35.8% | -10000.0% | |
| TTM EBIT | -$229.20M | -14.1% | -111.2% | -265.9% | -100.0% | |
| TTM Net Income | -$213.70M | -19.3% | -158.3% | -242.7% | -10000.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$141.71M | N/A | -59.5% |
| 3Y | -$54.11M | -317.7% | |
| 5Y | -$100.80K | N/A | >-9999.0% |
| All | $0.00 | N/A |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$226.03M | at low | |
| 3Y | -$226.03M | at low | |
| 5Y | -$226.03M | at low | |
| All | -$226.03M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MLTX?
As of today, MLTX TTM EBITDA is -$226.03M
What is MLTX TTM EBITDA most recent change?
MLTX TTM EBITDA was down -13.91% on September 30, 2025
What is 1-year change in MLTX TTM EBITDA?
MLTX TTM EBITDA is down -108.41% year-over-year
How far is MLTX TTM EBITDA from its all-time high?
MLTX TTM EBITDA vs all-time high is unknown
How does MLTX TTM EBITDA rank versus sector peers?
MLTX TTM EBITDA is higher than 5.88% of companies in Healthcare sector
When is MLTX next earnings release?
The next earnings release for MLTX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- MLTX Official Website www.moonlaketx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1821586/000182158625000022/0001821586-25-000022-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1821586/000182158625000006/0001821586-25-000006-index.htm
- MLTX Profile on Yahoo Finance finance.yahoo.com/quote/MLTX
- MLTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mltx